|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases response to substance |
ISO |
ABCC1 protein results in decreased susceptibility to Fosinopril |
CTD |
PMID:22095822 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases response to substance multiple interactions increases export |
ISO |
ABCC2 protein results in decreased susceptibility to Fosinopril ABCC2 protein affects the reaction [Fosinopril affects the export of Methotrexate] desloratadine inhibits the reaction [ABCC2 protein results in increased export of Fosinopril]; Loratadine inhibits the reaction [ABCC2 protein results in increased export of Fosinopril]; Methotrexate inhibits the reaction [ABCC2 protein results in increased export of Fosinopril] |
CTD |
PMID:22095822 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Adipor2 |
adiponectin receptor 2 |
increases expression |
EXP |
fosinopril increases expression of adipor2 mRNA in rat liver |
RGD |
PMID:19076162 |
RGD:2307264 |
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Afp |
alpha-fetoprotein |
multiple interactions |
ISO |
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein] |
CTD |
PMID:29859236 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Agt |
angiotensinogen |
decreases expression |
EXP |
Fosinopril results in decreased expression of AGT protein |
CTD |
PMID:12411096 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
multiple interactions |
EXP |
Fosinopril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BMPR2 mRNA] |
CTD |
PMID:17803470 |
|
NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA] |
CTD |
PMID:29859236 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased activity of GPT protein] |
CTD |
PMID:29859236 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Kl |
Klotho |
increases expression |
EXP |
Fosinopril results in increased expression of KL mRNA; Fosinopril results in increased expression of KL protein |
CTD |
PMID:21051829 |
|
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of MMP2 protein] |
CTD |
PMID:29859236 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions |
EXP |
Fosinopril results in decreased expression of MMP9 mRNA; Fosinopril results in decreased expression of MMP9 protein [Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 mRNA; [Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 protein |
CTD |
PMID:21051829 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Fosinopril inhibits the reaction [Diethylnitrosamine results in decreased expression of NFKB1 protein] |
CTD |
PMID:29859236 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nos3 |
nitric oxide synthase 3 |
affects expression |
EXP |
Fosinopril affects the expression of NOS3 mRNA; Fosinopril affects the expression of NOS3 protein |
CTD |
PMID:18209565 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Pde1a |
phosphodiesterase 1A |
affects expression |
EXP |
Fosinopril affects the expression of PDE1A mRNA; Fosinopril affects the expression of PDE1A protein |
CTD |
PMID:18209565 |
|
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
|
|
G |
Pde1c |
phosphodiesterase 1C |
affects expression |
EXP |
Fosinopril affects the expression of PDE1C mRNA; Fosinopril affects the expression of PDE1C protein |
CTD |
PMID:18209565 |
|
NCBI chr 4:85,300,858...85,777,948
Ensembl chr 4:85,300,858...85,863,219
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of RELA protein] |
CTD |
PMID:29859236 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Serpine1 |
serpin family E member 1 |
decreases expression multiple interactions |
EXP |
Fosinopril results in decreased expression of SERPINE1 mRNA; Fosinopril results in decreased expression of SERPINE1 protein [Valsartan co-treated with Fosinopril] results in decreased expression of SERPINE1 mRNA; [Valsartan co-treated with Fosinopril] results in decreased expression of SERPINE1 protein |
CTD |
PMID:21051829 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Slc15a1 |
solute carrier family 15 member 1 |
multiple interactions |
ISO |
Fosinopril inhibits the reaction [SLC15A1 protein results in increased uptake of glycylsarcosine] |
CTD |
PMID:18713951 |
|
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
|
|
G |
Slc15a2 |
solute carrier family 15 member 2 |
multiple interactions |
EXP |
Fosinopril inhibits the reaction [SLC15A2 protein results in increased uptake of glycylsarcosine] |
CTD |
PMID:18713951 |
|
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of TGFB1 protein] |
CTD |
PMID:29859236 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
decreases expression multiple interactions |
EXP |
Fosinopril results in decreased expression of TIMP1 mRNA; Fosinopril results in decreased expression of TIMP1 protein [Valsartan co-treated with Fosinopril] results in decreased expression of TIMP1 mRNA; [Valsartan co-treated with Fosinopril] results in decreased expression of TIMP1 protein |
CTD |
PMID:21051829 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of TNF protein] |
CTD |
PMID:29859236 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Fosinopril inhibits the reaction [Diethylnitrosamine results in increased expression of VEGFA protein] |
CTD |
PMID:29859236 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Alpk1 |
alpha-kinase 1 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of ALPK1 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 2:216,126,939...216,247,180
Ensembl chr 2:216,128,825...216,247,157
|
|
G |
Arc |
activity-regulated cytoskeleton-associated protein |
multiple interactions increases expression |
ISO |
Dizocilpine Maleate inhibits the reaction [phosphinothricin results in increased expression of ARC mRNA] |
CTD |
PMID:30557575 |
|
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
|
|
G |
Armc2 |
armadillo repeat containing 2 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of ARMC2 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr20:45,395,859...45,501,808
Ensembl chr20:45,394,127...45,504,819
|
|
G |
Ccdc180 |
coiled-coil domain containing 180 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of CCDC180 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 5:60,154,883...60,223,508
Ensembl chr 5:60,154,910...60,223,522
|
|
G |
Cfap43 |
cilia and flagella associated protein 43 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of CFAP43 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 1:246,625,259...246,712,438
Ensembl chr 1:246,625,262...246,712,443
|
|
G |
Cfap61 |
cilia and flagella associated protein 61 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of CFAP61 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 3:133,354,400...133,633,310
Ensembl chr 3:133,354,197...133,633,320
|
|
G |
Cftr |
CF transmembrane conductance regulator |
decreases expression |
ISO |
phosphinothricin results in decreased expression of CFTR mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Dpf3 |
double PHD fingers 3 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of DPF3 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 6:102,841,403...103,125,558
Ensembl chr 6:102,846,029...103,125,493
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
phosphinothricin results in increased expression of FOS protein |
CTD |
PMID:27031874 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fxr1 |
FMR1 autosomal homolog 1 |
increases expression |
ISO |
phosphinothricin results in increased expression of FXR1 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 2:116,884,167...116,937,590
Ensembl chr 2:116,884,248...116,937,590
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
ISO |
phosphinothricin results in increased expression of GFAP mRNA; phosphinothricin results in increased expression of GFAP protein |
CTD |
PMID:27031874 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Glul |
glutamate-ammonia ligase |
increases expression multiple interactions |
ISO |
phosphinothricin results in increased expression of GLUL mRNA phosphinothricin results in increased expression of and results in increased activity of GLUL protein |
CTD |
PMID:27031874 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
decreases expression |
ISO |
phosphinothricin results in decreased expression of INPP5A mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 1:194,190,086...194,380,429
Ensembl chr 1:194,190,393...194,380,428
|
|
G |
Iqank1 |
IQ motif and ankyrin repeat containing 1 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of IQANK1 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 7:107,724,962...107,759,163
Ensembl chr 7:107,724,997...107,759,162
|
|
G |
Kcnd3 |
potassium voltage-gated channel subfamily D member 3 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of KCND3 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
increases secretion |
ISO |
phosphinothricin results in increased secretion of KLK3 protein |
CTD |
PMID:20363314 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Klrg1 |
killer cell lectin like receptor G1 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of KLRG1 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 4:155,455,465...155,467,301
Ensembl chr 4:155,455,495...155,467,424
|
|
G |
Ms4a14 |
membrane spanning 4-domains A14 |
increases expression |
ISO |
phosphinothricin results in increased expression of MS4A14 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 1:207,949,423...207,964,937
Ensembl chr 1:207,949,426...207,964,937
|
|
G |
Nefh |
neurofilament heavy chain |
affects expression |
EXP |
phosphinothricin affects the expression of NEFH mRNA |
CTD |
PMID:22954530 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Odad2 |
outer dynein arm docking complex subunit 2 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of ODAD2 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr17:55,216,877...55,409,872
Ensembl chr17:55,218,991...55,409,399
|
|
G |
Peg3 |
paternally expressed 3 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of PEG3 mRNA |
CTD |
PMID:25477793 |
|
NCBI chr 1:67,097,874...67,124,692
Ensembl chr 1:67,097,904...67,124,671
|
|
G |
Phkg2 |
phosphorylase kinase catalytic subunit gamma 2 |
increases expression |
ISO |
phosphinothricin results in increased expression of PHKG2 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 1:182,184,362...182,197,124
Ensembl chr 1:182,184,650...182,197,124
|
|
G |
Plcd4 |
phospholipase C, delta 4 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of PLCD4 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 9:76,115,523...76,158,602
Ensembl chr 9:76,117,168...76,142,453
|
|
G |
Ppp1r36 |
protein phosphatase 1, regulatory subunit 36 |
increases expression |
ISO |
phosphinothricin results in increased expression of PPP1R36 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 6:95,138,526...95,159,102
Ensembl chr 6:95,139,007...95,159,102
|
|
G |
Pten |
phosphatase and tensin homolog |
affects expression |
ISO |
phosphinothricin affects the expression of PTEN mRNA |
CTD |
PMID:25477793 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Slc17a9 |
solute carrier family 17 member 9 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of SLC17A9 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 3:167,839,246...167,857,462
Ensembl chr 3:167,839,385...167,855,985
|
|
G |
Slc8b1 |
solute carrier family 8 member B1 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of SLC8B1 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr12:36,029,759...36,053,087
Ensembl chr12:36,029,760...36,053,031
|
|
G |
Spag16 |
sperm associated antigen 16 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of SPAG16 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 9:71,333,005...72,252,772
Ensembl chr 9:71,332,992...72,252,708
|
|
G |
Sulf1 |
sulfatase 1 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of SULF1 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 5:6,362,894...6,526,174
Ensembl chr 5:6,362,911...6,525,584
|
|
G |
Syt10 |
synaptotagmin 10 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of SYT10 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 7:120,857,698...120,920,863
Ensembl chr 7:120,862,972...120,920,863
|
|
G |
Tax1bp1 |
Tax1 binding protein 1 |
increases expression |
ISO |
phosphinothricin results in increased expression of TAX1BP1 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 4:81,821,991...81,877,906
Ensembl chr 4:81,821,989...81,879,100
|
|
G |
Tmtc1 |
transmembrane O-mannosyltransferase targeting cadherins 1 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of TMTC1 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 4:181,142,937...181,357,979
Ensembl chr 4:181,146,251...181,359,289
|
|
G |
Wnt2 |
Wnt family member 2 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of WNT2 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 4:46,328,408...46,374,673
Ensembl chr 4:46,333,998...46,374,402
|
|
G |
Zfpm2 |
zinc finger protein, multitype 2 |
decreases expression |
ISO |
phosphinothricin results in decreased expression of ZFPM2 mRNA |
CTD |
PMID:34597628 |
|
NCBI chr 7:71,678,658...72,116,209
Ensembl chr 7:71,678,880...72,116,205
|
|